Explore 3 Stock Ideas & Industry Insights Download Free Report

Stocks

Global Pharma Stocks Fall as Trump Plans to Cut Drug Prices

Novo Nordisk, which generates around 60% of its sales in the U.S., is among the biggest losers in early European trade. Continue Reading View Comments

EODHD | 12 May 2025

BC Q1 Earnings Call: Tariffs and Entry-Level Weakness Drive Cautious Outlook Despite Beat

Boat and marine manufacturer Brunswick (NYSE:BC) reported Q1 CY2025 results beating Wall Street’s revenue expectations , but sales fell by 10.5% year on year to $1.22 billion. On the other hand, next quarter’s revenue guidance of $1.2 billion was less impressive, coming in 3.7% …

EODHD | 12 May 2025

PEP Q1 Earnings Call: International Strength Offsets North America Volume Pressure; Tariffs Cloud Outlook

Food and beverage company PepsiCo (NASDAQ:PEP) reported Q1 CY2025 results topping the market’s revenue expectations , but sales fell by 1.8% year on year to $17.92 billion. Its non-GAAP profit of $1.48 per share was 1% below analysts’ consensus estimates. Is now the time …

EODHD | 12 May 2025

New Strong Buy Stocks for May 12th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Great Lakes Dredge & Dock GLDD: This company which is the largest provider of dredging services in the US conducting business to maintain and deepen shipping channels, reclaim land from …

EODHD | 12 May 2025

ALLE Q1 Earnings Call: Margin Expansion and Pricing Actions Amid Tariff Volatility

Security hardware provider Allegion (NYSE:ALLE) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 5.4% year on year to $941.9 million. Its non-GAAP profit of $1.86 per share was 11.2% above analysts’ consensus estimates. Is now the time to buy ALLE? Find …

EODHD | 12 May 2025

TPH Q1 Earnings Call: Premium Brand Focus Amid Housing Market Volatility

Homebuilder Tri Pointe Homes (NYSE:TPH) announced better-than-expected revenue in Q1 CY2025, but sales fell by 21.1% year on year to $740.9 million. Its non-GAAP profit of $0.70 per share was 42.9% above analysts’ consensus estimates. Is now the time to buy TPH? Find out …

EODHD | 12 May 2025

LKQ Q1 Earnings Call: Revenue Misses Expectations Amid Tariff and Market Headwinds

Automotive parts company LKQ (NASDAQ:LKQ) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 6.5% year on year to $3.46 billion. Its non-GAAP profit of $0.79 per share was in line with analysts’ consensus estimates. Is now the time to buy LKQ? …

EODHD | 12 May 2025

Morgan Stanley’s Wilson Warns US Stocks Not Yet in the Clear

(Bloomberg) -- Sentiment toward the US stock market is improving but it’s too early for investors to sound the all-clear, according to Morgan Stanley strategists. Most Read from Bloomberg A New Central Park Amenity, Tailored to Its East Harlem Neighbors As Trump Reshapes Housing …

EODHD | 12 May 2025

Down 61%, Is This Industry Disruptor's Stock a Buy Right Now?

Key Points GXO Logistics has fallen sharply since its peak in 2021. The company is more resilient to economic volatility. The stock is well priced at a forward P/E of less than 16. 10 stocks we like better than GXO Logistics › GXO Logistics …

EODHD | 12 May 2025

WST Q1 Earnings Call: Revenue Guidance Raised, Margins Impacted by Product Mix and Tariffs

Healthcare products company West Pharmaceutical Services (NYSE:WST) announced better-than-expected revenue in Q1 CY2025, but sales were flat year on year at $698 million. The company’s full-year revenue guidance of $2.96 billion at the midpoint came in 1.8% above analysts’ estimates. Its non-GAAP profit of …

EODHD | 12 May 2025
Support

Hi! How can we help you today?

Loading…